Licensed medical cannabis patients in the US state of Georgia can legally possess oils with less than 5% THC, but they can’t legally buy it. The Georgia Access to Medical Cannabis Commission was set to vote tomorrow, 25th January, on rules governing the cannabis program, but pending legal appeals are blocking access.

“We’re asking people to break the law,” said Sebastien Cotte, an activist and father of a boy with a terminal seizure disorder.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization